Clustering data with hclust algorithm for Eicosanoid profiles of dermal fibroblasts (Study ST001252)
Reversed phase NEGATIVE ION MODE (Analysis AN002078)Metabolite | Structure | F1 | F2 | F3 | F4 | F5 | F6 |
---|---|---|---|---|---|---|---|
6-keto PGF1α | ME293156 | 1.21 | 1.52 | 0.45 | 0.08 | 2.62 | 0.13 |
8-iso PGF2α | ME293157 | 0.87 | 1.43 | 0.44 | 0.37 | 2.54 | 0.35 |
PGD2 | ME293162 | 0.96 | NA | 0.41 | 0.11 | 3.44 | 0.08 |
15 HETE | ME293170 | 0.29 | 0.85 | 0.14 | 0.20 | 4.35 | 0.18 |
PGF2α | ME293161 | 0.72 | 1.13 | 0.29 | 0.19 | 3.49 | 0.18 |
5 HETE | ME293173 | 0.28 | 0.51 | 0.34 | 0.50 | 4.00 | 0.38 |
AA | ME293176 | 0.37 | 0.56 | 0.33 | 0.62 | 3.59 | 0.53 |
DHGLA | ME293177 | 0.37 | 0.65 | 0.33 | 0.73 | 3.30 | 0.62 |
PGE1 | ME293163 | 1.34 | 2.28 | 0.38 | 0.26 | 1.52 | 0.22 |
PGE2 | ME293160 | 1.70 | 2.67 | 0.23 | 0.10 | 1.20 | 0.10 |
12 HETE | ME293171 | 0.07 | 1.51 | 0.07 | 2.14 | 0.31 | 1.90 |
TXB2 | ME293158 | 0.25 | 1.70 | 0.21 | 2.01 | 0.24 | 1.59 |
PGA2 | ME293165 | 1.26 | 1.74 | 0.67 | 0.63 | 1.09 | 0.61 |
20-HETE | ME293169 | 1.13 | 0.89 | 1.14 | 0.86 | 1.16 | 0.81 |
5-iPF2α-VI | ME293159 | 0.88 | 1.11 | 1.00 | 1.11 | 1.00 | 0.88 |
Resolvin D1 | ME293164 | 0.99 | 1.01 | 0.99 | 1.00 | 0.99 | 1.02 |
(±)14(15)-EET | ME293172 | 0.54 | 0.96 | 0.51 | 1.02 | 2.04 | 0.93 |
EPA | ME293174 | 0.29 | 0.99 | 0.26 | 1.19 | 2.36 | 0.90 |
DHA | ME293175 | 0.27 | 1.13 | 0.29 | 1.53 | 1.62 | 1.15 |
(±)14,15-DHET | ME293166 | 0.65 | 1.22 | 0.63 | 1.41 | 0.88 | 1.21 |
(±)11,12-DHET | ME293167 | 0.41 | 1.22 | 0.40 | 1.52 | 1.04 | 1.41 |
(±)8,9-DHET | ME293168 | 0.40 | 1.22 | 0.37 | 1.44 | 1.27 | 1.30 |
Factors:
F1 | Genotype:cPLA2α KI | Treatment:Scratched |
F2 | Genotype:cPLA2α KI | Treatment:Unscratched |
F3 | Genotype:cPLA2α KO | Treatment:Scratched |
F4 | Genotype:cPLA2α KO | Treatment:Unscratched |
F5 | Genotype:Wild Type | Treatment:Scratched |
F6 | Genotype:Wild Type | Treatment:Unscratched |